NAACCR Item #3885: Lymphocytosis
Padding Character' '
|Item #||Length||Source of Standard||Year Implemented||Version Implemented||Year Retired||Version Retired||Column #|
|3885||1||NAACCR||1912 - 1912|
NAACCR XML: Tumor.lymphocytosis
Lymphocytosis is defined by an excess of lymphocytes in the blood. In staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), lymphocytosis is defined as an absolute lymphocyte count (ALC) greater than 5,000 cells/µL.
Lymphocytosis is a prognostic factor required for staging of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) in AJCC 8th edition, Chapter 79 Hodgkin and Non-Hodgkin Lymphomas. It is a new data item for cases diagnosed 1/1/2018+.
|0||Lymphocytosis not present
Absolute lymphocyte count = 5,000 cells/ µL
Absolute lymphocyte count > 5,000 cells/µL
|6||Lab value unknown, physician states lymphocytosis is present|
|7||Test ordered, results not in chart|
|9||Not documented in medical record
Lymphocytosis not assessed or unknown if assessed
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.